• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
GUO Qiao, SUN Jianguo, HUANG Lu, ZHANG Li, YU Xueli, LIU Jinghan, TANG Yiqun. Antioxidant and anti-atrial fibrillation effects of Guanfu base A[J]. Journal of China Pharmaceutical University, 2015, 46(2): 235-241. DOI: 10.11665/j.issn.1000-5048.20150217
Citation: GUO Qiao, SUN Jianguo, HUANG Lu, ZHANG Li, YU Xueli, LIU Jinghan, TANG Yiqun. Antioxidant and anti-atrial fibrillation effects of Guanfu base A[J]. Journal of China Pharmaceutical University, 2015, 46(2): 235-241. DOI: 10.11665/j.issn.1000-5048.20150217

Antioxidant and anti-atrial fibrillation effects of Guanfu base A

More Information
  • This study aimed at evaluating the antioxidant effects of Guanfu base A(GFA)on acetylcholine(Ach)/CaCl2(CaCl2 10 mg/mL, Ach 66 μg/mL)-induced atrial fibrillation(AF)in rats. SD rats were rando-mized into normal group, model group, GFA treatment groups(6 mg/kg, 12 mg/kg), Amiodarone(Ami)treatment group(50 mg/kg)and Lovastatin(Lov)treatment group(10 mg/kg). The AF durations were measured by electrocardiogram(ECG). The effective refractory periods(AERP)were measured in the left atrial appendage. Oxidative stress-related gene and protein expression was evaluated by RT-PCR and Western blot. The activity of antioxidant enzymes was measured by enzymatic assay. Results indicated that, in comparison with that in the vehicle-treated AF rats, treatment with GFA(6 mg/kg, 12 mg/kg, po), significantly shortened the AF duration and prolonged the AERP in rats. In addition, treatment with GFA reduced the levels of plasma and myocardium malondialdehyde, increased the activity of plasma superoxide dismutase in a dose-dependent manner. Moreover, treatment with GFA mitigated AF-up-regulated p22phox, p47phox, gp91phox, and p67phox NADPH oxidase expression, and AF-increased ratios of membrane to cytosolic Rac-1 in the atrium. It also significantly prevented AF-down-regulated atrial connexin40 expression in rats. Data suggested that GFA(6 mg/kg, 12 mg/kg)has potent anti-oxidant activity and inhibits oxidative-stress-related AF in rats.
  • [1]
    Schneider MP, Hua TA,Böhm M,et al.Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis[J].J Am Coll Cardiol,2010,55(21):2299-2307.
    [2]
    Korantzopoulos P,Kolettis T,Siogas K,et al.Atrial fibrillation and electrical remodeling:the potential role of inflammation and oxidative stress[J].Med Sci Monitor,2003,9(9):RA225-RA229.
    [3]
    Mccarty MF.Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies[J].Med Hypotheses,2010,75(2):141-147.
    [4]
    Arora S,Vaishya R,Dabla PK,et al.NAD(P)H oxidases in coronary artery disease[J].Adv Clin Chem,2010,50:65-86.
    [5]
    Bedard K,Krause KH.The NOX family of ROS-generating NADPH oxidases:physiology and pathophysiology[J].Physiol Rev,2007,87(1):245-313.
    [6]
    Reilly SN,Jayaram R,Nahar K,et al.Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation implications for the antiarrhythmic effect of statins[J].Circulation,2011,124(10):1107-1117.
    [7]
    Wang MW,Hao X,Chen K.Biological screening of natural products and drug innovation in China[J].Philos T R Soc B,2007,362(1482):1093-1105.
    [8]
    Zhang LY,Ji HF,Wang Q,et al.Effects of Guanfu base A on the electrical characterization of cardiac myocyted[J].J China Pharm Univ(中国药科大学学报),1991,22(6):354-358.
    [9]
    Huang X, Yang Y, Zhu J, et al. Comparative effects of guanfu base A and guanfu base G on HERG K+ channel[J].J Cardiovascr Pharm,2012,59(1):77-83.
    [10]
    Fan X,Chen Y,Xing J,et al.Blocking effects of acehytisine on pacemaker currents(If)in sinoatrial node cells and human HCN4 channels expressed in xenopus laevis oocytes[J].J Ethnopharmacol,2012,139(1):42-51.
    [11]
    Chen CL,Gong TT,Tang TQ,et al.Sprague Dawley rat model of atrial fibrillationthe[J].Lab Anim Sci Administ(实验动物科学与管理),2009,26(3):1-4.
    [12]
    Savelieva I,Camm J.Anti-arrhythmic drug therapy for atrial fibrillation:current anti-arrhythmic drugs,investigational agents,and innovative approaches[J].Europace,2008,10(6):647-665.
    [13]
    Tang YQ,Sun SJ,Yin YM,et al.Electrical remodeling of rat atrium induced by paroxysmal atrial fibrillation[J].Chin J Clin Pharm Ther(中国临床药理学与治疗学),2011,16(11):1205-1209.
    [14]
    Beckerman Z,Azran A,Cohen O,et al.A novel amiodarone-eluting biological glue for reducing postoperative atrial fibrillation first animal trial[J].J Cardiovasc Pharm T,2014,19(3):481-491.
    [15]
    Carnes CA,Chung MK,Nakayama T,et al.Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation[J].Circ Res,2001,89(6):e32-e38.
    [16]
    Kim YM,Guzik TJ,Zhang YH,et al.A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation[J].Circ Res,2005,97(7):629-636.
    [17]
    Ehrlich JR, Biliczki P, Hohnloser SH, et al. Atrial-selective approaches for the treatment of atrial fibrillation[J].J Am Coll Cardiol,2008,51(8):787-792.
    [18]
    Sanchez-Quinones J,Marin F,Roldan V,et al.The impact of statin use on atrial fibrillation[J].Qjm-Int J Med,2008,101(11):845-861.
    [19]
    Reilly SN,Jayaram R,Nahar K,et al.Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation implications for the antiarrhythmic effect of statins[J].Circulation,2011,124(10):1107-1117.
    [20]
    Umeji K,Umemoto S,Itoh S,et al.Comparative effects of pitavastatin and probucol on oxidative stress,Cu/Zn superoxide dismutase,PPAR-γ,and aortic stiffness in hypercholesterolemia[J].Am J Physiol-Heart C,2006,291(5):H2522-H2532.
  • Related Articles

    [1]HUO Zirui, PEI Jieyu, ZHAN Fangyi, XIE Shaowen, XU Jinyi, XU Shengtao. Research advances in small-molecule hydrophobic tagging protein degraders[J]. Journal of China Pharmaceutical University, 2025, 56(2): 252-263. DOI: 10.11665/j.issn.1000-5048.2024031301
    [2]YAO Chunlu, ZHANG Weijie, ZHANG Yunlong, DENG Zhaoxia, WANG Mengling, ZHANG Zuoling, WANG Chen, SONG Qinxin, ZOU Bingjie. Progress of single-cell protein imaging methods[J]. Journal of China Pharmaceutical University, 2024, 55(2): 147-157. DOI: 10.11665/j.issn.1000-5048.2024010205
    [3]CAO Jin, CHEN Hao, ZHANG Jing, ZHU Jianwei, CHEN Junsheng. Expression and purification of soluble recombinant antibody fragment and immunotoxin in Escherichia coli using Npu DnaE C-cleavage mutant[J]. Journal of China Pharmaceutical University, 2020, 51(2): 213-222. DOI: 10.11665/j.issn.1000-5048.20200213
    [4]TAO Linlin, HUO Meirong, XU Wei. Advances in the research of protein nanocarrier materials[J]. Journal of China Pharmaceutical University, 2020, 51(2): 121-129. DOI: 10.11665/j.issn.1000-5048.20200201
    [5]LI Qingmei, WANG Shuzhen. Advances of relationship between protein Neddylation and cancer[J]. Journal of China Pharmaceutical University, 2018, 49(3): 272-278. DOI: 10.11665/j.issn.1000-5048.20180303
    [6]ZHANG Xinran, LI Bo, DI Bin. Advances in racemization of protein amino acid[J]. Journal of China Pharmaceutical University, 2017, 48(4): 407-415. DOI: 10.11665/j.issn.1000-5048.20170404
    [7]Wu Mengqiu, WU Mengqiu, LU Gaoyuan, SHAO Chang, WANG Dandan, SUN Di, HAO Haiping, WANG Guangji. Mass spectrometry-based protein quantification and its application in pharmacokinetic research[J]. Journal of China Pharmaceutical University, 2015, 46(2): 129-140. DOI: 10.11665/j.issn.1000-5048.20150201
    [8]Progress in Protein Microarray and Its Applications[J]. Journal of China Pharmaceutical University, 2001, (5): 11-14.
    [9]IMPROVEMENT OF PROTEIN DETERMINATION WITH COOMASSIE BRILLIANT BLUE G-250 DYE[J]. Journal of China Pharmaceutical University, 1987, (2): 133-136.
    [10]Chen Qionghua. The Nutrition Value of Fermented Soy Bean Curd Protein[J]. Journal of China Pharmaceutical University, 1979, (2): 7-12.

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return